HOSPIRA ANNOUNCES IMPORTANT SAFETY INFORMATION REGARDING CARPUJECT SYRINGE SYSTEM AND THE POTENTIAL FOR OVERFILLPosted Friday, May 18, 2012
HOSPIRA ANNOUNCES IMPORTANT SAFETY INFORMATION REGARDING CARPUJECT SYRINGE SYSTEM AND THE POTENTIAL FOR OVERFILL -- Company requests healthcare professionals visually inspect and confirm the fill volume prior to administration -- LAKE FOREST, Ill., May 18, 2012 ? Hospira, Inc. (NYSE: HSP) announced today that it is notifying healthcare professionals regarding the potential for overfill in the pre-filled Carpuject? Syringe System, as some syringes may contain more medication than is stated on the label. The notice applies to Carpuject syringes and the 2mL iSecure? presentations of midazolam and ondansetron within expiration, which includes the following 15 drugs, all of which were manufactured between June 2010 and February 2012.